Podcasts about century cures act

If you're a physician with at least 5 years of experience looking for a flexible, non-clinical, part-time medical-legal consulting role… ...Dr. Armin Feldman's Medical Legal Coaching program will guarantee to add $100K in additional income within 12 months without doing any expert witness work. Any doctor in any specialty can do this work. And if you don't reach that number, he'll work with you for free until you do, guaranteed. How can he make such a bold claim? It's simple, he gets results…  Dr. David exceeded his clinical income without sacrificing time in his full-time position. Dr. Anke retired from her practice while generating the same monthly consulting income.  And Dr. Elliott added meaningful consulting work without lowering his clinical income or job satisfaction. So, if you're a physician with 5+ years of experience and you want to find out exactly how to add $100K in additional consulting income in just 12 months, go to arminfeldman.com.                                                          =============== Learn the business and management skills you need by enrolling in the University of Tennessee Physician Executive MBA program at nonclinicalphysicians.com/physicianmba. Get the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs.                                                                                                 =============== Dr. Meredith Loveless, an OB-GYN physician, shares her career shift from academic medicine to becoming Chief Medical Officer for CGS Administrators, a Medicare Administrative Contractor. After helping establish pediatric and adolescent gynecology programs at Johns Hopkins and the University of Louisville, she found herself carrying an unsustainable workload when her department shrank from five physicians to two—prompting her to explore non-clinical paths where she could apply her experience in medical writing and policy. She describes the world of Medicare administration, where Contract Medical Directors are responsible for creating Local Coverage Determinations—policies that guide what treatments and services Medicare will cover based on medical evidence. With the introduction of the 21st Century Cures Act, these policies now require greater transparency and rigor, opening the door for physicians with strong clinical and writing backgrounds to contribute meaningfully to federal healthcare decision-making. Dr. Loveless also outlines what the role involves day-to-day, including frequent travel, collaboration with subject matter experts, and the long timelines often needed to develop and implement coverage policies. She offers a grounded look at Medicare administration, challenging misconceptions while showing how physicians can move into policy work that influences care access and quality for millions of people—bringing clinical expertise into one of healthcare's most impactful arenas. You'll find links mentioned in the episode at  nonclinicalphysicians.com/chief-medical-officer-for-a-mac/

Andrew Mahler, Vice President of Privacy and Compliance Services, Clearwater, speaks with Kathleen Healy, Partner, Robinson Cole, and Robert Martin, Senior Legal Counsel, Mass General Brigham, about how health care compliance teams can build effective governance models, monitor legal risks, and prepare for enforcement activity related to artificial intelligence (AI). They discuss how to build an effective AI oversight framework and assess AI systems for bias and transparency, compliance considerations related to the Health Insurance Portability and Accountability Act and the 21st Century Cures Act, what federal agencies are signaling in terms of their AI priorities, and future trends shaping AI compliance in health care. Kate and Robert spoke about this topic at AHLA's 2025 Complexities of AI in Health Care conference in Orlando, FL. Sponsored by Clearwater. AHLA's Health Law Daily Podcast Is Here! AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this new podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.

A modern digital healthcare economy is impossible without a robust provider directory, which serves as the foundation for interoperability and crucial processes.  In this episode, Erin Weber, Chief Policy and Research Officer, discusses how CAQH supports provider directories, emphasizing the need for data accuracy and standardization through initiatives like universal group roster templates. She highlights the importance of interoperability and maintaining accurate data to ensure seamless care delivery and billing. Don Rucker, Chief Strategy Officer, talks about modern FHIR APIs and interoperability. He uses the analogy of domain name services on the internet and stresses the need for “computable interoperability” where data can be used in real time to improve care. They explain how the 21st Century Cures Act has impacted healthcare and how legacy systems need to be modernized. Don and Erin stress that this work is crucial for modern healthcare to evolve and deliver improved patient experiences.  Tune in and learn how these key changes are shaping the future of healthcare! Resources: Connect with and follow Erin Weber on LinkedIn. Follow CAQH on LinkedIn and visit their website. Connect with and follow Don Rucker on LinkedIn. Learn more about 1upHealth on their LinkedIn and website. Check out the latest annual CAQH Index Report here.

SummaryIn this episode, Sean and Terry discuss the evolving landscape of healthcare compliance, particularly focusing on HIPAA protections and the implications of the Cures Act. They explore the changes in regulations post-COVID, the importance of safeguarding mental health information, and the need for practices to stay updated with compliance policies. The conversation emphasizes the complexities of navigating healthcare regulations and the necessity for clear communication and understanding within the industry.TakeawaysTerry and Sean both experienced health issues recently, leading to a brief hiatus.There has been a noticeable change in HIPAA protections since COVID, with some practices not updating their policies.Certain medical records, especially in behavioral health, require extra protections under HIPAA.The Office of Civil Rights oversees HIPAA violations, not just Medicare.Explicit consent is required to disclose mental health information under HIPAA.The 21st Century Cures Act has implications for patient access to medical records.There are limitations on disclosing information that could lead to a patient being jailed.Practices need to ensure their staff is aware of updated compliance policies.HIPAA protections extend beyond the office and into patient interactions in public spaces.The healthcare industry is highly regulated, and changes in administration can impact compliance policies.

Dr. Anh Nguyen has built a career at the intersection of medicine, biotechnology, and public policy, bringing a unique perspective on how scientific innovation translates into real-world impact. As the co-founder and CEO of Alnair Therapeutics, Anh is leading the development of a novel drug delivery platform designed to transform cancer treatment, ensuring that therapies reach their targets more effectively while reducing side effects for patients. In this episode of Lab Rats to Unicorns, Anh shares his journey from clinical practice to biotech entrepreneurship, detailing the pivotal moments that led him to launch and lead innovative startups. He also reflects on his time working within the FDA and CMS, offering insider insights into the regulatory landscape and how policies like the 21st Century Cures Act shape the future of drug development. Beyond biotech, Anh discusses the parallels between endurance sports—he's completed multiple Ironman triathlons—and the perseverance required to navigate the highs and lows of building a biotech company. Whether you're an entrepreneur, a scientist, or just fascinated by the future of medicine, this conversation dives deep into the challenges, breakthroughs, and leadership lessons that define the evolving world of life sciences. Tune in for an inspiring discussion on resilience, innovation, and the drive to improve patient care through cutting-edge science and strategic execution.

When it comes to your health, having digitized information available for seamless sharing across multiple healthcare providers and other stakeholders -- including patients themselves -- is a clear benefit. But can certain actors disrupt the goal of interoperability? David Schwartz, a healthcare-focused antitrust lawyer, joins Jeny Maier and Matt Tabas to introduce us to the challenge of healthcare information blocking and what avenues are available to enforcers to address this behavior. Listen to this episode if you're curious about how competition law principles play a part in ensuring that patients receive more effective care through seamless exchange of electronic medical records. With special guest: David Schwartz, Partner, Bryan Cave Leighton Paisner Related Links: Everson J, Patel V, Adler-Milstein J., Information blocking remains prevalent at the start of 21st Century Cures Act: results from a survey of health information exchange organizations 2015 Information Blocking Report  HHS Assistant Secretary for Technology Policy (a/k/a the Office of National Coordinator) webpage on information blocking HHS ASTP/ONC webpage on information blocking exceptions Hosted by: Jeny Maier, Axinn, Veltrop & Harkrider LLP and Matt Tabas, Arnold & Porter Kaye Scholer LLP

Discover the fascinating world of digital health innovation with a leading expert in vascular surgery and digital health innovation, Dr. Oliver Aalami. In this insightful People of AI episode, Dr. Aalami shares his path to medicine, his passion for integrating technology in patient care, and his role as director of Stanford's Biodesign for Digital Health program. Explore the groundbreaking projects and initiatives shaping the future of healthcare. Resources: Stanford profile → https://goo.gle/49nPZF7 Biodesign for Digital Health → https://goo.gle/4fYf0ZV GitHub Stanford Spezi → https://goo.gle/4g9TZLS 21st Century Cures Act → https://goo.gle/41BwsPV Chapters: 0:00 - Introduction 0:33 - Dr. Alami's journey 6:08 - Biodesign for Digital health intro 24:29 - GitHub Spezi 26:44 - Where does AI come into digital health? 32:50 - Use cases and examples 41:27 - What does it mean to be a person of AI? 

Dr. Shaalan Beg and Dr. Arturo Loaiza-Bonilla discuss the potential of artificial intelligence to assist with patient recruitment and clinical trial matching using real-world data and next-generation sequencing results. TRANSCRIPT Dr. Shaalan Beg: Hello, and welcome to the ASCO Daily News Podcast. I'm Dr. Shaalan Beg, your guest host for the podcast today. I'm an adjunct associate professor at UT Southwestern's Simmons Comprehensive Cancer Center in Dallas and senior advisor for clinical research at the National Cancer Institute. On today's episode, we will be discussing the promise of artificial intelligence to improve patient recruitment in clinical trials and advanced clinical research. Joining me for this discussion is Dr. Arturo Loaiza-Bonilla, the medical director of oncology research at Capital Health in Philadelphia. He's also the co-founder and chief medical officer at Massive Bio, an AI-driven platform that matches patients with clinical trials and novel therapies.  Our full disclosures are available in the transcript of this episode.   Arturo, it's great to have you on the podcast today.  Dr. Arturo Loaiza-Bonilla: Thanks so much, Shaalan. It's great to be here and talking to you today.  Dr. Shaalan Beg: So we're all familiar with the limitations and inefficiencies in patient recruitment for clinical trials, but there are exciting new technologies that are addressing these challenges. Your group developed a first-in-class, AI-enabled matching system that's designed to automate and expedite processes using real-world data and integrating next-generation sequencing results into the algorithm. You presented work at the ASCO Annual Meeting this year where you showed the benefits of AI and NGS in clinical trial matching and you reported about a twofold increase in potential patient eligibility for trials. Can you tell us more about this study?  Dr. Arturo Loaiza-Bonilla: Absolutely. And this is just part of the work that we have seen over the last several years, trying to overcome challenges that are coming because of all these, as you mentioned, inefficiencies and limitations, particularly in the manual patient trial matching. This is very time consuming, as all of us know; many of those in the audience as well experience it on a daily basis, and it's resource intensive. It takes specialized folks who are able to understand the nuances in oncology, and it takes, on average, even for the most experienced research coordinator or principal investigator oncologist, 25 minutes per trial. Not only on top of that, but in compound there's a lack of comprehensive genomic testing, NGS, and that complicates the process in terms of inability to know what patients are eligible for, and it can delay also the process even further.  So, to address those issues, we at Massive Bio are working with other institutions, and we're part of this … called the Precision Cancer Consortium, which is a combination of 7 of the top 20 top pharma companies in oncology, and we got them together. And let's say, okay, the only way to show something that is going to work at scale is people have to remove their silos and barriers and work as a collaborative approach. If we're going to be able to get folks tested more often and in more patients, assess for clinical trials, at least as an option, we need to understand further the data. And after a bunch of efforts that happened, and you're also seeing those efforts in CancerX and other things that we're working on together, but what we realize here is using an AI-enabled matching system to basically automate and expedite the process using what we call real-world data, which is basically data from patients that are actually currently being treated, and integrating any NGS results and comparing that to what we can potentially do manually. The idea was to do multi-trial matching, because if we do it for one study, yeah, it will be interesting, but it will not show the potential applicability in the real world.  So with all that background, the tool itself, just to give you the punchline of it, was proven highly effective in terms of efficiency. We were able to increase the number of potential matches, and not only that, but reducing the time to the matching. So basically, instead of spending 25 minutes, it could be done in a matter of seconds. And when you compound all that across multiple clinical trials, in this case, it was several sponsors coming together, we were able to reduce the manual effort of seeing patients and testing for clinical trials to basically 1 hour when it would have otherwise taken a ridiculous amount of time. And it was quantified as 19,500 hours of manual work, compared to 1 hour done by the system to uniquely match a cohort of about 5,600 patients that came into the platform. And this was across 23 trials. Now imagine if we can do it for the 14,000 clinical trials currently in clinicaltrials.gov.   So for us, this kind of was an eye-opening situation that if we can increase not only the efficiency but find even more trials by integrating comprehensive genomic testing, which in this case was a twofold increase in eligibility for clinical trials, that gives us not only the opportunity for optimized processes using AI but also a call to action that there is still a lot of under-genotyping. And I know American Cancer Society and ASCO and many others are working hard on getting that into fruition, but we need to have systems that remind us that certain patients are not tested yet and that can improve not only real patients, but the R&D and the process of innovation in the future. Dr. Shaalan Beg: Yeah, it's always an important reminder that even some of the highest impact IT solutions or AI solutions are most effective if they can be integrated into our normal clinical processes and into the normal workflow that we have in our clinics to help clinicians do their work quickly and more efficiently. Can you talk about how, over the last few years, the availability of NGS data in our electronic medical record (EMR) has evolved and whether that's evolving for the better? And what are some next steps in terms of making that data available at EMR so that such solutions can then pull that data out and do clinical trial matching?  Dr. Arturo Loaiza-Bonilla: Yes. So one of the things that we have seen over the last couple of years is because of the applicability of the 21st Century Cures Act, there is less “information blocking,” which is patients not being able to access their information in real time. Now, with the appearance of health exchanges, with patient-centric approaches, which is something that many innovators, including ours, are trying to apply, it's really becoming more relevant. So it's not only helping us to find the patients when they really need to get tested, but also is giving us the opportunity to put those patients into the right treatment pathway when found. Something that's still a challenge and I think we can work by being more collaborative once again – is my dream – is having these pre-screening hubs where no matter where you are in your cancer journey, you just go into that funnel and then are able to see, “Okay, you are in the second-line setting for non-small cell lung cancer, EGFR-mutated. Now, do you have a meta amplification, then you go for this study or this trial. Oh, you haven't been tested yet. You should get tested. You're a pancreas cancer patient who is KRAS wild type; well, there is a significant chance that you may have a biomarker because that's where most patients are enriched for.” So having that opportunity to at scale, just for the whole country, to get those patients access to that information, I think is crucial for the future of oncology. And I think you working at the NCI, more than most, know how the impact of that can help for those underrepresented patients to get more access to better treatment options and whatnot. And we can activate clinical trials as well in new models, decentralized models, adjusting time models, all those things can be leveraged by using biomarker testing in real time. Identification when the patient really needs a trial option or a medication option, because the data is telling us when to activate that in real time. Dr. Shaalan Beg: And identifying the patient for a potential clinical trial is one challenge. In oncology, given a lot of our trials, we are looking to enroll people at a specific time in their disease journey. So we call it first-line or second-line or third-line, becomes the next challenge. So just knowing someone has mutation number 1, 2, or 3 isn't enough to say they would be eligible for a second-line BRAF X, Y and Z mutation at a given trial. I've heard you talk a lot about this last-mile navigation for people once you've identified that they may be a soft match for a clinical trial. Can you talk about what you've seen in the ecosystem being developed on how AI is helping both clinics and patients navigate this last mile from the time they're identified for a clinical trial to the time they actually receive cycle 1, day 1? Dr. Arturo Loaiza-Bonilla: Yeah, absolutely. And that is such a critical point because, as you know, we have helped tons of patients getting trial options in thousands of cases. But even my own patients, I give them a report for trial options and they're like, “Okay, I still need help.” And we have been talking with ASCO, with the American Cancer Society, and many other very good teams, and what we see as an opportunity in technology here is leveraging those cancer journeys to know when the patient really has the opportunity to enroll in a trial, because this is a very dynamic environment. Not only the patient's condition changes because their cancer progresses, the hemoglobin changes, the cancer moves from one place to the other, and there's nuances in between, but also new medications are coming up, studies open and close, sites open and close.  So having this information as a hub, as what we call a command center, is the key to make this happen. And we can use the same tools that we use for Uber or for Instacart or whichever thing you want to do; it's already the same concept. When you need groceries, you don't need groceries every day. But Amazon gives you a ding that's like, “Well, I think you may be running out of milk,” because they already know how often you buy it, or just having the data behind the scenes of how typically these, in this case, patient journeys, may manifest based on the biomarker. So let's say a smoldering multiple myeloma is not the same across. One patient with biomarkers that make them very high risk, the risk of progressing to a multiple myeloma, first-line treatment-eligible patient is going to be much different than someone who has better risk cytogenetics. So using that tool to optimize the cancer journeys of those patients and being able to notify them in real time of new trial options, and also knowing when the patient really has that disease progression so there's a time of activation for trial matching again, the same way you get a credit score for buying a house, then you know exactly what options are in front of you at that very moment. And that is the last-mile component, which is going to be key. What we have seen that we feel is important to invest on, and we have invested heavily on it, is that until the patient doesn't sign the consent form for the clinical trial, that patient is completely unknown to most people. The site doesn't know them because they haven't been there, and they may be there, but they don't know about the options sometimes. But no one's going to invest in getting that patient to the finish line. There's a lot of support for patients on trials, but not before they enroll on trials. And we feel that this is a big opportunity to really exponentially grow the chances of patients enrolling in trials if we support them all the way from the very time they get diagnosed with cancer in any setting. And we can help that patient on a very unique journey to find the trial options using technology. So it's very feasible. We see it once again in many other equally complex tasks, so why not do it in oncology when we have all the bonafides across wanting to do this. Dr. Shaalan Beg: Can you give examples of where you are seeing it done outside of oncology that's a model that one can replicate? Dr. Arturo Loaiza-Bonilla: I mean, oncology is the toughest use case to crack. You have experiences with DCTs in the past and all that. So the big opportunities are for patients, for example, in psychiatry, when they need certain counseling and help. We see that also in medical devices, when people have diabetes and they really need a device specifically for that unique situation, or also for patients with cardiovascular risk that they can in real time get access to novel therapeutics. And that's how they have been able to enroll so quickly. And all these GLP-1 inhibitors, all those models are really almost completely decentralized nowadays in something that we can extrapolate for oncology once we have aligned the ecosystem to make it see them. This is something that we can really revolutionize care while we manage all the complex variables that typically come with oncology uses.  Dr. Shaalan Beg: I would imagine while you translate those learnings from outside of oncology into oncology, a lot of those processes will be human and AI combination activities. And as you learn more and more, the human component becomes a smaller fraction, and the technology and the AI becomes more of a component. Are you seeing a similar transition in the clinical trial matching space as well? Dr. Arturo Loaiza-Bonilla: Yes. So that's why people say humans are going to be replaced. They're not. Patients still want to see a human face that they recognize, they trust. Even family members of mine want to hear from me, even if they are in the top place in the world. What we can change with technology are those things that are typically just friction points. In this case, information gathering, collecting records, getting the data structured in a way that we can use it for matching effectively, knowing in real time when the patient progresses, so we can really give them the chances of knowing what's available in real time. And collecting the information from all these other stakeholders. Like, is the site open? Is the budget approved for that place? Is the insurance allowing the specific … do they have e-consent? Those things can be fully automated because they're just burdensome. They're not helping anyone. And we can really make it decentralized for e-consent, for just getting a screening. They don't need to be screened at the site for something that they're going to receive standard of care. We can really change that, and that's something that we're seeing in the space that is changing, and hopefully we can translate it fully in oncology once we are getting the word out. And I think this is a good opportunity to do so. Dr. Shaalan Beg: You talked about your dream scenario for clinical trial matching. When you think about your dream scenario as a practicing oncologist, what are the AI tools that you are most excited about making their way into the clinic, either wishful thinking or practically? Dr. Arturo Loaiza-Bonilla: I typically get feedback from all over the place on doing this, and I also have my own thoughts. But I always come to this for a reason. We all became physicians and oncologists because we like being physicians. We like to talk to patients. We want to spend the time. I tell folks in my clinic, I will see a thousand patients all the time as long as I don't have to do notes, as long as I don't have to place orders. But of course, they will have to hire 1,000 people ancillary to do all the stuff that we do.  If we can go back and spend all that time that we use on alert fatigue, on clicking, on gathering things, fighting insurance, and really helping align those incentives with clinical trials and biomarker testing and really making it a mankind or a humankind situation where we're all in this really together to solve the problem, which is cancer, that will be my dream come true. So I don't have to do anything that is clerical, that is not really helping me, but I want to use that AI to liberate me from that and also use the data that is generated for better insights. I think that I know my subject of expertise, but there's so many things happening all the time that it is hard to keep up, no matter how smart you are. If the tool can give me insights that I didn't even know, then leverage that as a CME or a board certification, that would be a dream come true. Of course, I'm just dreaming here, but it's feasible. Many of these ideas, as I mentioned, they're not new. The key thing is getting them done. The innovative part is getting stuff done, because I'm sure there's a gazillion people who have the same ideas as I did, but they just don't know whom to talk to or who is going to make it happen in reality. And that's my call to action to people: Let's work together and make this happen. Dr. Shaalan Beg: Well, Arturo, thanks a lot for sharing your insights with us today on the ASCO Daily News Podcast. Dr. Arturo Loaiza-Bonilla: Well, thank you so much for the time and looking forward to having more exchanges and conversations and seeing everyone in the field. Dr. Shaalan Beg: And thank you to our listeners for your time today. You'll find a link to the studies discussed today in the transcript of this episode. And if you value the insights that you hear on the podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts.   Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.   Find out more about today's speakers:  Dr. Shaalan Beg    @ShaalanBeg Dr. Arturo Loaiza-Bonilla @DrBonillaOnc   Follow ASCO on social media: @ASCO on Twitter   ASCO on Facebook   ASCO on LinkedIn     Disclosures:    Dr. Arturo Loaiza-Bonilla: Leadership: Massive Bio Stock and Other Ownership Interests: Massive Bio Consulting or Advisory Role: Massive Bio, Bayer, PSI, BrightInsight, Cardinal Health, Pfizer, Eisai, AstraZeneca, Regeneron, Verily, Medscape Speakers' Bureau: Guardant Health, Bayer, Amgen, Ipsen, AstraZeneca/Daiichi Sankyo, Natera   Dr. Shaalan Beg:    Consulting or Advisory Role: Ispen, Cancer Commons, Foundation Medicine, Genmab/Seagen    Speakers' Bureau: Sirtex    Research Funding (An Immediate Family Member): ImmuneSensor Therapeutics    Research Funding (Institution): Bristol-Myers Squibb, Tolero Pharmaceuticals, Delfi Diagnostics, Merck, Merck Serono, AstraZeneca/MedImmune

If you were writing the sequel to the 21st Century Cures Act, what would you include?

Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health tech topics and trends of the day. In this episode, Gregory Stein, Founder, Chief Executive Officer, and Director of Shadowbox, joins us to discuss how the 21st Century Cures Act could impact interplay within the healthcare industry, particularly interoperability as a means of addressing what has become, according to recent testimony before the U.S. Senate Budget Committee, a $950 billion administrative burden.   What We Discussed in This Episode Why was Shadowbox founded, and how is its technology poised to impact the long tail of healthcare? How have the Cures Act and other recent regulations been a game changer? Where is the IT vendor industry headed in terms of adapting to the Cures Act requirements and interoperability? What are some existing disparities between those inside and outside the regulatory certified health IT framework that could create additional gaps in the industry and the ability to access quality care? Beyond the potential for catastrophic health consequences, what other gaps have arisen as the industry has continued to evolve? How should regulators go about addressing some of these gaps?   About Gregory A. Stein Gregory A. Stein is the Founder, Chief Executive Officer, and Director of Shadowbox, a venture funded healthcare software company whose mission is to elevate patient care by making patient data easy to access and safe to share no matter where it resides. A former legislative aide on Capitol Hill, Greg was an original investor in Millennium Health and previously served as the company's Vice President of Strategic and Community Affairs, helping it grow to over 1,500 employees and $1.8BN in enterprise value.  Beyond the boardroom, Greg has dedicated his career to community service. He co-founded the Safe Homes Coalition to battle prescription drug abuse and served as Chairman of the San Diego County Taxpayers Association for seven years, leading the charge for better government efficiency.   About Sara Shanti A partner in the Corporate Practice Group in the Sheppard Mullin's Chicago office and co-lead of its Digital Health Team, Sara Shanti's practice sits at the forefront of healthcare technology by providing practical counsel on novel innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital healthcare and regulatory compliance matters, including artificial intelligence (AI), augmented and virtual reality (AR/VR), gamification, implantable and wearable devices, and telehealth. At the cutting edge of advising on "data as an asset" programming, Sara's practice supports investment in innovation and access to care initiatives, including mergers and acquisitions involving crucial, high-stakes and sensitive data, medical and wellness devices, and web-based applications and care.   About Phil Kim A partner in the Corporate and Securities Practice Group in Sheppard Mullin's Dallas office and co-lead of its Digital Health Team, Phil Kim has a number of clients in digital health. He has assisted multinational technology companies entering the digital health space with various service and collaboration agreements for their wearable technology, along with global digital health companies bolstering their platform in the behavioral health space. He also assists public medical device, biotechnology, and pharmaceutical companies, as well as the investment banks that serve as underwriters in public securities offerings for those companies. Phil also assists various healthcare companies on transactional and regulatory matters. He counsels healthcare systems, hospitals, ambulatory surgery centers, physician groups, home health providers, and other healthcare companies on the buy- and sell-side of mergers and acquisitions, joint ventures, and operational matters, which include regulatory, licensure, contractual, and administrative issues. Phil regularly advises clients on matters related to healthcare compliance, including liability exposure, the Stark law, anti-kickback statutes, and HIPAA/HITECH privacy issues. He also provides counsel on state and federal laws, business structuring formation, employment issues, and involving government agencies, including state and federal agencies.   Contact Info Gregory A. Stein Sara Shanti Phil Kim   Resources Shadowbox   Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month.  If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show. This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.  

On episode 481 of The Nurse Keith Show nursing and healthcare career podcast, Keith interviews Jean Ross, MHA, BSN, RN, the co-founder of Primary Record, a nurse-designed app that helps families organize and collaboratively share their family's health information across multiple platforms and electronic medical record systems. It's a medical record jungle out there, and Primary Record is Ms. Ross's answer to the growing confusion. In the course of their conversation, Keith and Jean discuss the trends in healthcare that have led to us navigating the multitude of online patient portals and repositories of information that can make caring for ourselves and our loved ones a complicated and frustrating task. Ms. Ross also elucidates facts about the little-known 21st Century Cures Act, a law that stipulates that all healthcare consumers have a legal right to be able to view and download their online medical records. In fact, organizations that fail to provide such access can face enormous fines. As a nurse, Jean Ross knows that providing better care starts with knowing the full story of patients. Her passion centers on supporting the family around complex patients who are instrumental in carrying out the plan of care in the home. She co-founded Primary Record after 12 years of critical care nursing and running a care coordination company, where she saw first hand the problems families and community businesses face when their health information does not follow them. Jean serves as the chairwoman of Community Heath Network's Indy Region Patient and Family Advisory Council, a volunteer on Indiana's AARP legislative team, and a Dementia Champion with Dementia Friends Indiana. Jean is the eldest daughter of two aging parents, a mother of three sons, Jonas, Ian, and Otis, and the proud wife of Dr. Christian Ross. Connect with Jean Ross and Primary Record: PrimaryRecord.com Facebook Instagram TikTok LinkedIn

Over 60% of patients say that having fast electronic access to their complete medical record is important. It is a safety issue, a quality issue and your legal right. The 21st Century Cures Act went into effect in 2021, but the Federal Government just decided on the penalties incurred by providers if they create any unnecessary hassle in making your records available. Kelsey's story is about the hassle she faced in the healthcare system including how hard it was to simply get a copy of her radiology report. Key Takeaway: Know Your Rights Under the 21st Century Cures Act Examples of Information Blocking Requesting lab, xray or biopsy results and being told, "Wait for your next visit so the doctor can discuss it with you." Lack of access to the clinical notes written about you in the office or hospital by your doctor, specialists or other ancillary providers (ie physical therapist, social work) Charging excessive fees for access to your medical records. Tip: Request digital/electronic access to information because the "reasonable" cost for paper requests can get pricey. Delay or refusal to transfer of medical records to another doctor/specialist/provider What To Do If You Think Information Blocking Is Happening To You Know how to log in to your healthcare portal Sign any forms required for sharing/transferring information Mention your right to information under the 21st Centure Cures Act. Contact the Office of the Inspector General (OIG) to report potential information blocking. Use the OIG Hotline via the web at https://oig.hhs.gov/fraud/report-fraud/index.asp or by phone at 1-800-HHS-TIPS (1-800-447-8477). How to get in touch with Archelle Email: SpeakUpForYourHealth@gmail.com Instagram:  https://instagram.com/speakupforyourhealth Facebook: https://www.facebook.com/speakupforyourhealth

Commemorating the 20th anniversary of the Office of the National Coordinator for Health Information Technology (ONC). The episode revisits key milestones and initiatives from the ONC's inception in 2004 by executive order of President George W. Bush to its recent accomplishments. Topics include the High Tech Act, the evolution of health IT infrastructure, the significance of electronic health records, and the challenges faced in achieving interoperability. Bill reflects on what worked, what didn't, and the lessons learned for the future, particularly in the context of AI and healthcare technology. The episode also highlights various strategic plans and legislation, such as the 21st Century Cures Act, which have shaped the healthcare IT landscape.00:00 Introduction and Overview00:59 The Birth of ONC03:03 Early Challenges and Investments04:01 The High-Tech Act and Its Impact05:28 Advancements and Unintended Consequences10:48 Strategic Plans and Final Rules12:11 Recent Developments and Future Directions13:14 Conclusion and Reflections

In this podcast, Hong Linda Li, MD, discusses a recently published article on the effect of 21st Century Cures Act implementation on patient access of their radiology reports at a multicampus health system. ARTICLE TITLE - Patient Access of Their Radiology Reports Before and After Implementation of 21st Century Cures Act Information-Blocking Provisions at a Large Multicampus Health System

It turns out I was wrong about the 21st Century Cures Act. But only in technical terms, really. The reality of the situation that dental practice owners are in is still a dire one, perhaps even more serious than we previously realized. In this episode of The Patient First Podcast, I explain why we need a correction in our understanding of the federal legislation pertaining to the handling of dental patient information. In short, dentists and DSOs of all sizes are obligated by HIPAA to make patient data accessible to their patients, and the 21st Century Cures Act prohibits actions that unnecessarily limit accessibility to data. I also explain what is currently the ONLY solution that allows dental practices to comply with both HIPAA and Cures Act regulations. Learn what my team and I currently know about patient data accessibility in this episode and follow this space to stay up-to-date with new clarifications. I'm Dr. Bryan Laskin—entrepreneur, author, dentist and advocate for the dental Standards and innovations that will continue to make oral healthcare more efficient, effective and patient-focused. Learn more about the biggest issues fragmenting our industry: DentalDisorder.com Get your practices compliant with the only solution that gives patients access to their own dental data: Toothapps.com

Travel RN Coach (@lindseys_leisures), Lindsey, joins Nurses Uncorked to discuss her recent viral video in which a patient made alarming threats against their former ER nurse at Peace Health Southwest Medical Center. The repeated threats included very specific identifying details of the nurse's family, begging the question, how were they able to find this information?   The answer lies in The 21st Century Cures Act, first passed in 2016. Many medical professionals remain unaware of The Cures Act. And patients often do not understand the complications it poses to their care. Why do patients have access to nurses' full names? Is this a safety risk that employers should mitigate? What role do electronic health records, like Epic, Cerner, or Meditech play? Should patients have real-time access to their medical records? Join us as we break down The Cures Act and it's ramifications.    References: https://www.congress.gov/114/bills/hr34/BILLS-114hr34enr.pdf National Public Radio (NPR): Winners and losers with the 21st Century Cures bill. http://www.npr.org/sections/health-shots/2016/12/02/504139105/winners-and-losers-if-21st-century-cures-bill-becomes-law.    Follow Lindsey: https://www.tiktok.com/@lindseys_leisures?_t=8k1XIaaTQr9&_r=1 https://www.instagram.com/lindseys_leisures?igsh=MTd5Z2tleHdwYXJsbg== https://lindseysleisures.net/ https://youtube.com/@lindseys_leisures?si=LiWRkky8bgNVbera   New episodes of Nurses Uncorked every Tuesday. Help us grow by giving our episodes a download, follow, like the episodes and a 5 ⭐️ star rating! Please follow Nurses Uncorked at!  https://www.tiktok.com/@nurses.uncorked?_t=8drcDCUWGcN&_r=1 https://instagram.com/nursesuncorked?igshid=OGQ5ZDc2ODk2ZA== https://youtube.com/@NursesUncorkedL https://www.facebook.com/profile.php?id=100094678265742&mibextid=LQQJ4d You can listen to our podcast at: https://feed.podbean.com/thenurseericarn/feed. https://podcasts.apple.com/us/podcast/nurses-uncorked/id1698205714 https://spotify.link/8hkSKlKUaDb https://nursesuncorked.com     DISCLAIMER: This Podcast and all related content [published or distributed by or on behalf of Nurse Erica, Nurse Jessica Sites or Nurses Uncorked Podcast is for informational purposes only and may include information that is general in nature and that is not specific to you. Any information or opinions expressed or contained herein are not intended to serve as or replace medical advice, nor to diagnose, prescribe or treat any disease, condition, illness or injury, and you should consult the health care professional of your choice regarding all matters concerning your health, including before beginning any exercise, weight loss, or health care program.  If you have, or suspect you may have, a health-care emergency, please contact a qualified health care professional for treatment.   Any information or opinions provided by guest experts or hosts featured within website or on Nurses Uncorked Podcast are their own; not those of Nurse Jessica Sites, Nurse Erica or Nurses Uncorked Company.  Accordingly, Nurse Erica, Nurse Jessica Sites and the Company cannot be responsible for any results or consequences or actions you may take based on such information or opinions.

Dr. Adam Robinson, an internal medicine physician and founder of Aimedica, joined CJ Wolf, MD to explore the promises and pitfalls presented by AI in the healthcare landscape. Dr. Robinson provides valuable insights into the current state of electronic medical records, the impact of the 21st Century Cures Act, and the potential for AI to revolutionize patient care. Tune in to our latest episode, “Beyond the Buzzwords: Understanding AI's Role in Healthcare,” to hear CJ and Adam's discussion on: - Existing challenges with electronic medical records, such as data interoperability issues and the siloed nature of patient information. - The implications of the 21st Century Cures Act and its role in making healthcare data more transparent and interoperable. - Successful applications of AI in imaging specialties, highlighting the potential for improved diagnostics. - The current lack of comprehensive regulations for AI in healthcare and predictions around the emergence of potential FDA regulations in the future.

January 12th, 2023: This conversation with Micky Tripathi, National Coordinator for Health Information Technology at ONC, explores the intricate balance between policy, technology, and business within healthcare. How is the intersection of these domains reshaping healthcare IT, and what challenges and rewards come with navigating this nexus? They also touch upon the implications of the 21st Century Cures Act and the role of information blocking in modern healthcare. What does the future hold for health IT professionals in the wake of these regulatory changes, and how will these adjustments impact patient care and provider interactions? Furthermore, the discussion highlights the potential of TEFCA (The Trusted Exchange Framework and Common Agreement) in revolutionizing health information exchange. Could TEFCA be the key to overcoming previous communication barriers in public health emergencies? Join us as we explore these pivotal topics and their implications for the future of healthcare.Key Points:Home Based CareInformation Blocking RegulationsTEFCA and Public HealthPatient and Provider InteractionEthics of Sharing InformationSubscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

The complexity of the healthcare system often results in miscommunication, difficulty obtaining medical records, and delays in care. Kelsey shares her frustrating experience when she had a bout of abdominal pain but finally broke through the bureaucracy to get the surgery she needed.  Key Takeaway: Escalate You have a right to all your medical records including immediate access to your test results. The 21st Century Cures Act requires that patients have immediate electronic availability to nearly all test results, medication lists, and clinical notes. Don't use an urgent care as a substitute for having a primary care physician. While urgent care clinics are great for simple problems like sore throats and urinary tract infections, establishing a relationship with a regular doctor will assure some continuity. Contracts between your health insurer and in-network providers often prohibit the provider from requiring up-front payment.  Links Instagram:  https://instagram.com/speakupforyourhealth Facebook: https://www.facebook.com/speakupforyourhealth

In 2021, federal rules from the 21st Century Cures Act mandated that most clinical notes be made available in real-time, online and free of charge to patients. This practice, commonly known as “open notes,” was a significant step towards enhancing medical information transparency–– a vital step in reinforcing trust in the provider-patient relationship. However, it also introduced complexities, raising questions as to what to include in the notes. “The ethical analysis does not always align with the legal analysis, and these are conversations that ethicists are aware of,” Steven Bondi, MD, JD, says. Dr. Bondi, a lawyer turned doctor, is renowned for his expertise on the Cures Act, Open Notes and Electronic Medical Records. He specializes in pediatric medicine at Golisano Children's Hospital and is an associate professor within the Department of Pediatrics at the University of Rochester Medical Center. “I think that knowledge is important, and we need to know what the law says and what its parameters are and when we can use the exceptions,” Dr. Bondi says. Dr. Bondi recommends multiple resources on this topic. He suggests visiting healthit.gov and navigating to their information blocking section for informative FAQs and webinars. He also recommends the Guttmacher Institute as a source for general knowledge around adolescent health and privacy. Lastly, he explains that he was recently a part of the American Academy of Pediatrics' committee on medical liability and risk management where he helped produce a monthly column called ‘Pediatricians in Law.' This episode was recorded at the 2023 American Academy of Pediatrics National Conference and Exhibition. Some highlights from this episode include:  How to navigate difficult situations and avoid labels  The role that ethics play in this discussion Confidentially in adolescents by state Biggest pitfalls and gray areas  For more information on Children's Colorado, visit: childrenscolorado.org    

The Department of Health and Human Services released a set of three proposed monetary penalties for healthcare providers–both organizations and physicians–that engage in so-called information blocking. That practice interferes with, prevents, or discourages access, exchange, or use of electronic health information. It was banned in 2016's 21st Century Cures Act. Today, Micky Tripathi, head of the Office of the National Coordinator for Health IT (ONC), joins the podcast to talk more about what information blocking looks like among healthcare providers and what the proposed penalties aim to do. You can read HHS' proposed rule here. Be sure to tune in for the second part of our conversation tomorrow. Hosted on Acast. See acast.com/privacy for more information.

Thank you for tuning into The Dish on Health IT's 2023 end-of-year recap. Point-of-Care Partners' (POCP) subject matter experts, including, Pooja Babbrah, Pharmacy and PBM Practice Lead; Jocelyn Keegan, Payer Provider Practice Lead; and Kim Boyd, Regulatory Resource Center Lead, gathered to discuss their top 3 health IT milestones for 2023 and their expectations for 2024. They also delved into the highly anticipated final version of the Interop 3, focused on advancing interoperability and improving prior authorization rules. Offering insights and advice, they guided listeners on approaching the initial review of this significant final rule. Point-of-Care Partners extends warm holiday wishes and a Happy New Year to all. Host, Pooja Babbrah kicked off the episode informing listeners that this episode will be a special format. POCP has subject matter experts galore so this episode will bring together a small group of POCPers to look back at 2023, discuss what 2024 will have in store and talk a bit about the anticipated final Interop 3 rule.Cohosts Jocelyn Keegan, recently honored as the DirectTrust Interoperability Hero, and Kim Boyd, a contributor steeped in policy knowledge and serving as POCP's Regulatory Resource Center Lead, introduced themselves before the trio transitioned to the main discussion.They contemplated a format for the day, aiming to dedicate the first half of the conversation to a round-robin, where each would share their personal top three events or trends from 2023. Pooja referenced the HIT Perspectives 2023 trends article, outlining POCP's collective trends. However, today's discussion allowed each participant to present their individual lists before delving into the much-anticipated final rule.Top of FormKim initiated the round robin by expressing that her top priority is healthcare interoperability, acknowledging its vast scope emerging from the 21st Century Cures Act and beyond. Within this expansive interoperability landscape, she highlighted the advancements within the FHIR community, predicting a swifter adoption of FHIR than previously witnessed. Her second ranking milestone revolves around artificial intelligence and machine learning, particularly their rapid uptake and integration into policy. Kim anticipated a more robust policy oversight of AI in the future. Her third notable milestone encompasses telehealth and telepharmacy, noting that the COVID-19 pandemic significantly increased patient reliance on remote visits for healthcare.Jocelyn followed, emphasizing that her list complemented Kim's perspective, offering a different angle. Her primary inclusion highlighted the industry's transition into implementation mode in 2023, witnessing real-world progress and widespread adoption of FHIR at scale.Jocelyn provided examples supporting these observations. The first involves the reaction to the proposed attachments rule, released alongside the prior authorization proposed rule. While many organizations expressed their belief that attachments might not be crucial for future progress, the responses to the Interop 3 proposed rule were predominantly positive.Her second HIT milestone relates to AI but primarily focuses on acknowledging and addressing the baked-in bias potentially inherent in AI and other advanced technologies. She highlighted the steps included in the HTI-1 proposed rule, aiming to mitigate bias and initiate discussions on ensuring the unintentional disruption of the path towards equity.Jocelyn's third milestone centers on TEFCA, highlighting the progress made and the anticipated clarification expected in 2024 regarding its scope and limitations.She connected TEFCA back to the first topic, emphasizing the necessity for alignment between the TEFCA infrastructure, rule framework, and the emerging API world. There have been ongoing discussions and industry feedback stressing the need for better alignment between the FHIR roadmap and the TEFCA roadmap as the industry shifts towards more real-time interactions.Finally, Pooja presented her list, with pharmacy interoperability holding the top spot as her absolute milestone. She expressed her honor in participating in the HITAC Pharmacy Interoperability Task Force, emphasizing POCP's long-standing advocacy for integrating pharmacists into continuity of care discussions. She highlighted the importance of this focus in bridging access gaps, facilitating genomics testing, and building momentum for sharing data with pharmacists. This includes ensuring their access to patient records and their ability to share data with the broader care team, a significant development.Her second and third priorities revolved around emerging trends in pharmacy with broader implications. Second on her list was Pharmacogenomics, involving genetic testing to discern the effectiveness or ineffectiveness of certain medications for specific patients. Pooja's third priority was digital therapeutics, an area where POCP has already made strides. She noted the growing emphasis, not only for pharmacies in understanding how to administer these therapeutics but also for payers in determining coverage policies.The discussion then pivoted to sharing reactions and perspectives on each other's lists. Kim expressed her delight in hearing pharmacy interoperability as Pooja's top priority. She highlighted the dichotomy within the healthcare ecosystem, emphasizing the divide between pharmacy services and NCPDP standards on one side, and clinical services with HL7 standards, including FHIR, on the other. Kim noted the increasing convergence between these realms, particularly with enhanced collaboration between NCPDP and HL7. She anticipated continued advancements in NCPDP concerning pharmacogenomics, digital therapeutics, social determinants, and the flow of relevant health data.When questioned, Jocelyn emphasized the criticality of integrating pharmacy into data flow and recognizing pharmacists as integral members of the care team. She stressed the impact of provider shortages in recent engagements with the US healthcare system.Jocelyn echoed Kim's perspective on the alignment of pharmacy and clinical standards, emphasizing their collaborative synergy rather than competition. She emphasized the need to ensure the right patient data reaches the appropriate care team members, including pharmacists, at the opportune moment, asserting that this alignment significantly enhances patient care.Jocelyn highlighted that technology is designed to facilitate transitioning from one standard to another. She emphasized the increasing significance of robust data exchange, particularly the exchange of quality data, between payers and pharmacies as the industry transitions towards value-based care.Agreeing with Jocelyn, Pooja explained the challenges in integrating pharmacists into value-based care contracts consistently. However, she noted that as data exchange between pharmacies, other healthcare settings, and payers improves, barriers diminish. Pooja underscored the broader benefits of enhancing pharmacy interoperability, emphasizing advantages not only for pharmacists but also for providers and payers.Highlighting the pivotal role of pharmacists, Pooja stressed their potential as invaluable resources for gathering social determinants of health data. She emphasized their significance in care delivery, identifying patient needs, and facilitating connections with community services. Given the frequency of pharmacist-patient interactions, she emphasized the criticality of collecting and sharing this information with the broader provider team.The conversation then shifted to the Interop 3 – Advancing Interoperability and Improving Prior Authorization rule, expected to be released by the end of 2023 or early 2024. Kim initiated the discussion, focusing primarily on the prior authorization aspect of the rule, acknowledging its broader scope.Kim emphasized the crucial need to establish transparency and automation to address the delays in treatment caused by prior authorization or impeding patients' understanding of their coverage when a PA is not approved. The rule encompasses various APIs facilitating exchanges among payers, providers, and patients, utilizing the Da Vinci implementation guides.Regarding industry feedback on the proposed Interop 3 rules, Kim highlighted the notably high volume of comments, predominantly expressing overwhelming positivity. Approximately 68% of the comments agreed with the rule's intent. Although some HIPAA-related concerns were expressed, very few disagreed with the rule overall, which was intriguing given its extensive scope. Providers consistently voiced their desire for a more efficient prior authorization process, advocating for faster turnaround times and increased transparency regarding reasons for denial.Kim underscored the significance of the inclusion of the patient access API, stressing its value for all individuals as patients. She emphasized the importance of augmented access and transparency, not only concerning clinical information like test results but also regarding payer information related to coverage and reasons for prior authorization denial.Jocelyn aligned with Kim's overall assessment and expressed disappointment over the proposed rules' omission of automation for specialty medications or treatments covered under the medical benefit. She highlighted this overlooked area, expressing disappointment at its continued exclusion.One thing that brought Jocelyn immense satisfaction was the inclusion and acknowledgment of the Da Vinci Guides' role, which significantly boosted morale. There has been noticeable maturity and widespread adoption of Da Vinci guides this year.Jocelyn expressed surprise at the absence of staggered deadlines in the proposed Interop 3 rule. From the Da Vinci community perspective, strong opinions have been consistently voiced to all HHS colleagues—ONC and CMS—over the past couple of years, emphasizing the importance of promoting gradual progress rather than imposing substantial leaps. Hence, the alignment of everything with the 2026 deadline was quite unexpected.Pooja expressed her appreciation for Jocelyn's mention of the absence of specialty medication. She highlighted the stakeholders' growing interest in addressing specialty automation. Notably, many specialty medications require prior authorization, making it surprising that a proposed rule focused on prior authorization didn't include items covered under the medical benefit, such as specialty medications.The discussion shifted towards offering advice to listeners on how to approach their initial review of the final rule when it's released. Pooja inquired if there were any specific strategies to consider. Jocelyn openly admitted that she would start her review by performing a search using control + F for the words "Da Vinci" before delving into noting the specific IGs named and understanding the timeline. Additionally, she highly recommended reviewers commence with the rule's introduction, as it sets the expected scope for the details.Kim humorously mentioned her plan to break out the eggnog before diving into the review, expressing eagerness due to its overdue nature. She echoed Jocelyn's emphasis on paying special attention to standards requirements, specifications, and particularly the timelines. She's curious if any staggering will be introduced.Kim highlighted her interest in uncovering any mentions of TEFCA and seeking details regarding prior authorization. Anticipating stakeholders' keenness for the timeline, she pondered how organizations less proactive in their approach might adjust their interoperability roadmaps.The trio acknowledged the waiting game as they anticipated the final rule, expecting it to drop within a week or a few weeks. In closing the episode, they shifted focus to their expectations for progress in 2024, sharing their final thoughts.Expressing gratitude, Jocelyn thanked Pooja, Kim, and all the dedicated Da Vinci members committed to transforming healthcare. She emphasized the privilege of their work and the influential role they play in driving industry progress forward.Continuing, Jocelyn emphasized the importance of stakeholders having a plan in place, having selected partners, and scoped out project requirements, considering the multiple requirements in proposed rules like HTI-1 or disincentives related to information blocking. With policy activity accumulating, starting work becomes increasingly challenging if stakeholders haven't initiated their projects.She highlighted that interoperability and emerging policies transcend mere technology, impacting fundamental business transformation. It's about establishing collaborative frameworks with partners, providers, suppliers, pharmacies, and community members.Recognizing the learning curve, Jocelyn stressed the need to leverage collective experience, emphasizing the necessity of investing in building skilled professionals for this transformative journey.Additionally, Jocelyn pointed out the considerable activity at the state level, highlighting states like Washington, California, and Utah potentially setting more aggressive deadlines than anticipated by CMS.Kim contributed by mentioning the Office of the National Coordinator's rule-making efforts around certification. Specifically, she referenced the FY2025 rule encompassing real-time prescription benefit and the new SCRIPT standard, particularly pertinent to pharmacy interoperability.Agreeing with Jocelyn's state-level observation, Kim highlighted a Wisconsin Bill allocating $500,000 annually to drive the adoption of real-time prescription benefit tools. States like Wisconsin actively support moving patient empowerment solutions forward where progress has been slower.In 2024, increased AI-related policy activity is expected, not only at the federal level but also within certain states as they unveil details regarding the integration of artificial intelligence in healthcare. Privacy and security will be pivotal aspects of these developments. TEFCA's prominence, especially in the initial six months of 2024, cannot be overstated.POCP houses experts deeply entrenched in these areas, dedicating their days to aiding organizations in navigating the landscape, aligning strategies with competitive trends and policy shifts, as they are intrinsically intertwined. Further industry consolidations are anticipated, influencing healthcare interoperability and patient care delivery.Looking ahead, there's a breadth of promising developments on the horizon, but staying abreast of these changes requires daily vigilance—a facet in which we aim to empower and assist. Pooja echoed these sentiments about 2024, emphasizing the significance of pharmacy interoperability.She highlighted the recent recommendations from high-tech quarters, advocating for pharmacy inclusion at the table. Pooja referenced the Sequoia annual conference, where the importance of not overlooking pharmacists was underscored. She hinted at discussions swirling around the potential formation of a pharmacy workgroup under the Sequoia project.The recommendations stemming from the HITAC pharmacy interoperability task force aimed to unite stakeholders and emphasize various focal points in the field.Reflecting on 2024, Pooja's closing thoughts emphasized the importance of collaboration. Encouraging individuals with substantial pharmacy knowledge and hands-on experience in operability to step up and contribute, she urged for their active involvement to ensure the comprehensive inclusion of this expertise.Closing the episode, Pooja extended her gratitude to her esteemed colleagues, Jocelyn Keegan and Kim Boyd, and expressed sincere appreciation to the audience for their unwavering support of The Dish on Health IT, underscoring its immense value to everyone involved.

Hosts Phil Kim and Sara Shanti introduce Health-e Law, a new podcast produced by Sheppard Mullin's Digital Health Team focusing on the exciting and sometimes explosive interaction between technology and law in the healthcare space. Join our hosts as they engage with industry innovators and thought leaders, exploring AI, virtual reality, and other emerging technologies poised to reshape healthcare as we know it. They'll also dissect recent regulatory and legislative efforts in the health and wellness arena while hopefully having a bit of fun along the way! If you're struggling to stay on top of the rapidly evolving landscape that is healthcare tech, these brief, bite-sized episodes, will keep you in the know.   About Sara Shanti A partner in the Corporate Practice Group in the Sheppard Mullin's Chicago office, Sara Shanti's practice sits at the forefront of health-technology by providing practical counsel on healthcare innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital and novel healthcare regulatory compliance matters, including artificial intelligence and machine learning (AI/ML), augmented and virtual reality (AR/VR), data assets and privacy, gamification, implantable and wearable devices, and telehealth. Sara has deep experience advising clients on data use and protection under Part 2, HIPAA, GINA, and state privacy laws, such as BIPA and CCPA, and multinational border transmissions. She also assists clients in implementing compliance programs, launching health innovations and investments, and responding to governmental investigations. Her experience extends to consumer and patient rights, including under the American Disabilities Act and Section 1557, medical staff relationships, and navigating the evolving regulatory landscapes for next-generation technology. She also has extensive experience navigating telehealth prescribing laws, including the Ryan Haight Act, and with entities offering services in sensitive healthcare areas, such as behavioral health, fertility, genetics, and substance abuse. At the cutting-edge of advising on “data as an asset” programming, red team technology reviews, and information blocking and interoperability under the 21st Century Cures Act, Sara's practice also includes mergers and acquisitions involving crucial, high-stakes, and sensitive data in areas of digital health platforms, medical and wellness devices, and web-based applications and treatment.   About Phil Kim A Partner in the Corporate and Securities Practice Group in Sheppard Mullin's Dallas office, Phil Kim advises various types of healthcare providers in connection with transactional and regulatory matters. He counsels healthcare systems, hospitals, ambulatory surgery centers, physician groups (including non-profit health organizations, or NPHOs), home health providers, and other healthcare companies on the buy- and sell-side of mergers and acquisitions, joint ventures, and operational matters, which include regulatory, licensure, contractual, and administrative issues. Phil has a particular interest in digital health. He has assisted a number of multinational technology companies entering the digital health space with various service and collaboration agreements for their wearable technology. He also assists public medical device, biotechnology, and pharmaceutical companies, as well as the investment banks that serve as underwriters involved in the public securities offerings for such healthcare companies. Phil regularly advises clients on matters related to healthcare compliance, including liability exposure, the Stark law, anti-kickback statutes, and HIPAA/HITECH privacy issues. He also provides counsel on state and federal laws, business structuring formation, employment issues, and involving government agencies, including various state Medicaid agencies, the Texas Medical Board, and Medicare Administrative Contractors.   Contact Info: Sara Shanti Phil Kim Digital Health Attorneys | Sheppard Mullin   Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Google Podcasts, Amazon Music, or Spotify. It helps other listeners find this show. This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.  

About Jason Sherwin:Jason Sherwin is the Senior Director of Business Development at Clear. He is a passionate strategic thinker who is driven to challenge long-held healthcare standards. Jason has 13 years of expertise in the health technology field, focusing on product planning and commercial growth. In his role at Clear, Jason works cross-functionally with executives and other leaders in marketing, operations, and IT to maximize outcomes.Jason completed his MBA at the Stern School of Business, which enabled him to apply the principles he learned to his real-world work. His expertise in designing successful strategies for managing organizational change and gauging success was further boosted by his specialization in Leadership & Change Management. Jason also completed his Bachelor of Science at Skidmore College in 2009.About Ryan Howells:Ryan Howells is Principal at Leavitt Partners and Program Manager at CARIN Alliance. He focuses on healthcare policy and interoperability issues, working with key stakeholders, including the White House, Congress, HHS, and VHA. His role is instrumental in driving consumer access to healthcare data and enabling interoperability in the healthcare ecosystem.Ryan is also a Member of the Medicaid Information Technology Architecture (MITA) Governance Board at the Centers for Medicare & Medicaid Services, intending to provide strategic direction and tactic oversight. Ryan has earned his Master of Arts in Health Services Administration at the University of Southern California.Things You'll Learn:In healthcare, identity is critical. Getting the patient's identity wrong isn't an option.Streamlining healthcare through digital identity can significantly reduce provider costs and improve patient matching.The 21st Century Cures Act, Fire APIs, and identity-proof credentials are revolutionizing how consumers access their healthcare data.Individuals can prove their identity, for example, when checking in for an appointment with their doctor, through a unique digital identity, similar to taking a selfie.The goal is to place patients in control of their health information, providing a seamless experience.Trust is a crucial aspect, making the digital identity a reliable solution for healthcare data.Resources:Connect with and follow Jason on LinkedIn.Visit CLEAR on their website and follow them on LinkedIn.Connect with and follow Ryan on LinkedIn.Learn more about Leavitt Partners on this website and LinkedIn.Visit CARIN Alliance on their website and follow them on LinkedIn. 

With thousands of followers on social media, Dr. Robert Oubre, aka “The Doctor of Documentation,” will make his Talk Ten Tuesdays debut on Tuesday, Nov. 7, when he will be the broadcast's special guest.Dr. Oubre will be reporting on what documentation considerations should be given when patients are reading physician notes appearing on the monitor screen of the electronic medical record (EMR). He is expected to cite the 21st Century Cures Act, which went into effect April 5, 2021, mandating that U.S. healthcare providers give access to all health information in their EMRs “without delay” and without charge to their patients. Many providers feared the passing of this legislation, but more than two years later, have those fears proved justified?Dr. Oubre is also expected to raise rhetorical questions such as when physicians should reconsider some of the habitual language they may use in medicine that may be offensive to patients.Angela Comfort, former American Health Information Management Association (AHIMA) senior director for coding services-turned-senior healthcare consultant, will substitute for Dr. Erica Remer. Comfort currently serves as the transformational leader for Montefiore Health System.The weekly live broadcast will also feature these outstanding segments and thought leaders:• Coding Report: Laurie Johnson, senior healthcare consultant for Revenue Cycle Solutions, LLC, will report on the latest coding news.• SDoH Report: Tiffany Ferguson, a subject-matter expert on the social determinants of health (SDoH), will report on the news that's happening at the intersection of coding and the SDoH.• News Desk: Timothy Powell, CPA, will anchor the Talk Ten Tuesdays News Desk.• Point of View: The forementioned Angela Comfort, the Talk Ten Tuesdays guest cohost, will report on a subject that has caught her attention.Security UnfilteredCyber Security can be a difficult field to not only understand but to also navigate....Listen on: Apple Podcasts Spotify

In this episode of the Something Runderful Podcast, Coach Ally talks to David Covington about his projects for suicide prevention.  David Covington - David W. Covington, LPC, MBA, is CEO and President of RI International (d/b/a for Recovery Innovations, Inc.). He is a behavioral health innovator, entrepreneur, and storyteller. He is also a partner in Behavioral Health Link, founder of the Five Lanes Crisis Partners family of companies and Crisis Now Academy consulting and training business, producer of the Moving America's Soul on Suicide film series and founder of the international initiatives Crisis Talk and Hope Inc. Stories. David also hosts and curates the popular weekly 988 “Crisis Jam” Learning Community in partnership with SAMHSA and NASMHPD.A licensed professional counselor, Covington received an MBA from Kennesaw State University and an MS from The University of Memphis. He previously served as vice president at Magellan Health responsible for executive and clinical operations of the $750 million Arizona contract. He is a member of the U.S. Department of Health and Human Services Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC), established in 2017 in accordance with the 21st Century Cures Act to report to Congress on advances in behavioral health.Covington is a two-time national winner of the Council of State Governments Innovations Award. He also competed as a finalist in the 2009 Harvard Kennedy School Innovations in American Government Awards Program on behalf of the Georgia Crisis and Access Line, which was featured in Bloomberg Businessweek. He started his career in ministry where he served as a senior pastor for Grace Communion International, during a period of radical transformation from recognized cult to inclusion with the National Association of Evangelicals.Covington has served on the National Action Alliance for Suicide Prevention Executive Committee since 2010. In 2011, he co-led the Action Alliance task force on clinical care which founded the international movement Zero Suicide. He was also the vice-chair of the National Suicide Prevention Lifeline Steering Committee from 2005 until 2020, and he is a past president of the American Association of Suicidology. In addition, Covington has served on numerous committees and task forces on clinical care and crisis services, including the National Council for Mental Wellbeing Board of Directors. https://davidwcovington.com/https://www.instagram.com/davidwcovington/https://www.facebook.com/david.covingtonhttps://www.linkedin.com/in/davidwcovington/https://www.youtube.com/davidcovingtonJoin my FREE Facebook Group, Weightloss for Runners --> https://www.facebook.com/groups/1308394592682971Follow me on Instagram @something_runderful --> https://www.instagram.com/something_runderful/?hl=enBOOK A FREE 20 Minute Coaching Call with me --> https://calendly.com/somethingrunderful/free-coaching-callContact me - ally@somethingrunderful.com Disclaimer: This podcast offers health, fitness, and nutritional information, it is designed for educational purposes only. The information does not replace medical advice, diagnosis, or treatment. If you have any other concerns or questions about your health, you should always contact your physician or healthcare provider. Use any information provided at your own risk. To reduce and avoid injury, you will want to check with your doctor before beginning any fitness program. By performSupport the show

Jay Keese is CEO of Capitol Advocates, a Washington D.C. based policy and advocacy firm specializing in healthcare issues. Jay has represented physicians for decades, starting with a career in government relations at American Medical Association. Over the years, he has won important legislative and regulatory battles for doctors, employers, payers, states, health technologists, hospitals, device and pharmaceutical manufacturers on critical health care delivery and payment reforms. During the COVID-19 pandemic, Jay worked closely with physician groups, Congress and both administrations on critical waivers to state and federal laws that allow practices to fully utilize digital health services such as telehealth and remote patient monitoring to provide better care in a public health emergency.Jay currently runs several national healthcare stakeholder coalitions. He serves as Executive Director of the Direct Primary Care Coalition. He was instrumental in drafting a provision in the Affordable Care Act (ACA) which defines Direct Primary Care (DPC) as a medical service offered outside of insurance which meets ACA Essential Health Benefits criteria. He then played a major role in the passage of over 30 related state laws and regulations clarifying the treatment of DPC medical services and bringing value-based primary care arrangements to Medicaid and State Employees' health programs. He also leads advocacy work for the Partnership to Fight Chronic Disease (PFCD), a coalition of patients, providers, community leaders, businesses, unions, and health policy experts, committed to improving health outcomes and controlling costs by slowing the spread of preventable chronic disease by implementing more value-based payment and delivery reforms. He played a role in shaping many of these innovative reforms in the ACA and has helped implement programs like physician direct contracting with the Centers for Medicare and Medicaid Services (CMS) and the CMS Innovation Center (CMMI).Jay has worked with doctors, health technologists and software manufacturers for decades to support the adoption of health information technology and patient care applications. He worked with a broad bipartisan group of stakeholders on the creation of a risk-based regulatory framework for smartphone apps adopted by the Food and Drug Administration—part of the Food and Drug Administration Safety and Innovation Act (FDASIA). He helped expand and implement many of these principles in provisions included in the 21st Century Cures Act. He began his career as an aide to the late Senator John Heinz (R-PA), a member of the Senate Finance Committee and Chairman of the Senate Aging Committee. Jay has been a guest lecturer at the Georgetown University School of Medicine and serves as an Adjunct Professor of Health Benefit Design at the University of Lynchburg, teaching a master's Download Hint's 2023 Employer Trends in Direct Primary Care here: https://bit.ly/3EZAYej Learn more about Med Mastery: HERESupport the showVisit the DPC SWAG store HERE!Let's get SOCIAL! Follow My DPC Story! FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube

Michael chats with Dr. Pawan Jindal, MD, CEO of Darena Solutions, A St. Louis-based tech company that delivers EHR and other health IT solutions for vendors and patients. How has technology, the 21st Century Cures Act, and patient literacy aided in the new evolution of data interoperability (not totally there yet though)

Although the 21st Century Cures Act was enacted in 2016, many hospitals today continue to struggle with effective implementation of its provisions and the goal of preserving patient access to medical records.Seven years later, however, meaningful guidance regarding its enforcement is here. One of the provisions requires developers not to engage in information blocking.Now that the guardrails are in place and the risks have been identified, Monitor Monday's own physician and attorney Dr. John K. Hall will review the related enforcement actions and the penalties during the next live edition of the long-running Internet broadcast.Broadcast segments will also include these instantly recognizable features:Monday Rounds: Ronald Hirsch, vice president of R1 RCM, will make his Monday rounds.The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullen, will report the latest news about auditors.Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.Legislative Update: Cate Brantley, a legislative analyst for Zelis, will report on current healthcare legislation.

Data enablement has the power to transform American Healthcare. It can foster trust between patients and clinicians and make healthcare more accessible, affordable and equitable. This future of an open and connected health ecosystem may seem elusive, but it's not out of reach. Technology will not hold us back — instead our biggest challenge will be creating a value-based model of care where new innovations can thrive.   This week we our joined by Dr. David Feinberg, the Chairman of Oracle Health. Dr. Feinberg is committed to advancing thought leadership and strategy related to unleashing the healing power of data through an open and connected healthcare ecosystem.  Previously Dr. Feinberg served as president and CEO of Cerner, now Oracle Health, where he led teams delivering tools and technology to improve the patient and caregiver experience. He has also served as the VP of Google Health, and he served as the President and CEO of Geisinger where he led a complex turnaround and guided Geisinger's transition to value-based care.  Episode Bookmarks: 01:30 Introduction to Dr. David Feinberg, Chairman of Oracle Health. 02:45 The massive generation of data by humankind in the modern day (projected to be 175 Zettabytes by 2025). 03:45 Approximately 80% of healthcare data today is unstructured. 04:30 People are dying unnecessarily and suffering poor outcomes despite the amount of data generated by the healthcare system. 05:30 "Healthcare fundamentally is people caring for people. Data is secondary; the primary aspect of healthcare is trust.” 06:30 Making Electronic Health Records usable is of paramount importance (PCPs Need 27 Hours a Day to Do Their Best Work!) 07:00 Digitizing the medical record has made clinical workflows humanly impossible and compromises trust. 07:30 The vision for an open and connected health data ecosystem. 08:45 The Meaningful Use program did nothing for EHR usability (an example of the Gartner Hype Cycle). 10:00 Dr. Feinberg's clinical and executive leadership background provided a great lesson in technology adoption. 11:00 Can there be a high level of technology adoption in healthcare like Google dominates the non-healthcare marketplace? 12:30 We have solved for interoperability, but healthcare lacks a level of usability to allow a true longitudinal health record. 14:00 Motivating doctors for high performance ultimately comes down to the data scorecard. 15:00 Knowing the game (volume vs. value) and the promise of data enablement in value-based care. 16:00 The 21st Century Cures Act and the path forward in interoperability. 17:00 Can scalable FHIR-based interoperability and Open APIs eventually reach critical mass in the U.S. to improve population health? 19:45 Dr. Feinberg describes the two points of failure by technology companies trying to disrupt the healthcare ecosystem. 20:30 How Oracle Cerner is designing an intelligent, cloud-enabled platform to change healthcare for the better. 22:00 An example of disruption with Internet Banking and how application of those principles could change the healthcare system. 23:45 Digitization of medical records was a requisite first step. 24:00 Integration and normalization of disparate data sets provides an opportunity to create data intelligence. 25:00 How Larry Ellison's impatience for healthcare disruption clashes with the realities of the industry. 26:30 Recognizing the "life and death" aspects of healthcare transformation. 27:00 Making incremental progress with a digitized medical record…and then COVID happens to accelerate value-based care! 29:00 Workforce burnout and EHR usability - “Simplicity is the ultimate art of sophistication.” 30:00 “Value-based care is ultimately the best way to address the root cause of burnout in the workforce.” 30:45 The need for UX in the design of EHR applications to optimize physician workflow. 31:30 Results in usability redesign — ex: 19% reduction in nursing time at the terminal,

Since the beginning of the year, the Office of the National Coordinator for Health IT has rolled out several new updates to existing interoperability frameworks, including the 21st Century Cures Act, Trusted Exchange Framework and Common Agreement (TEFCA) and U.S. Core Data for Interoperability (USCDI) to improve standards that enable better health information exchange. National Coordinator for Health IT Micky Tripathi explains the latest with these frameworks and discusses the implications on areas like artificial intelligence, interoperability, health equity, data security and more.

For the rare disease community, there is a common motto “alone we are rare, together we are strong”. Advocacy organizations play this important role in connecting families of rare disease , amplifying their voices and helping to improve health outcomes for people living with rare diseases. Today's podcast guest is Annie Kennedy who has over three decades of experience in advocacy work. A veteran leader in the rare disease patient advocacy movement, Annie joined the EveryLife Foundation in 2018, where she led the National Economic Burden of Rare Disease study, the development of the ICD Code Roadmap, and the community-driven Guide to Patient Involvement in Rare Disease Therapy Development. Annie previously held leadership roles at Parent Project Muscular Dystrophy (PPMD) and the Muscular Dystrophy Association (MDA). She is a sought-after advisor to patient-centered organizations and initiatives across the nonprofit and government sectors. If you are new to advocacy work or a seasoned advocate, become inspired by Annie's story to carry forward despite the road to advocacy work is non-stop, exhausting and at times, bumpy with many ups and down. Join this collective energy to advocate for rare diseases research.    Podcast Interview Questions:  1. For over three decades your advocacy work has been critical to amplifying the voices and you are currently the Director of Chief of Policy, Advocacy, & Patient Engagement for the EveryLife Foundation for Rare Diseases. Can you share with our listeners the mission of the EveryLife Foundation? What were major accomplishment made? And how can they get involved? 2. EveryLife Foundation for Rare Diseases also plays important roles in advancing newborn screening advocacy in the United States. What is your vision for how stakeholders across newborn screening and the rare disease community can work together? 3. EveryLife Foundation led a study to assess the total economic burden of 379 rare diseases in 15.5 million individuals in the United States in 2019.  The total economic burden was $997 billion. What were your key takeaways from this important study and how can the results inform researchers, clinicians, policy makers, and other key stakeholders? 4. Prior to the EveryLife Foundation, you were involved in the Parent Project Muscular Dystrophy (PPMD) and the Muscular Dystrophy Association (MDA). In that time, you helped lead the legislative efforts around passage and implementation of the MD-CARE Act (2001, 2008, 2014), the Patient Focused Impact Assessment Act (PFIA) which became the Patient Experience Data provision within the 21st Century Cures Act (sec 3001). Congratulations, these are incredibly impactful efforts. Can you tell our listeners  about the ‘behind the scenes' activities that were undertaken to lead these efforts and the implementation strategy.  5. February is a special month. Every year, last day of February is a day to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. What are some rare disease day activities taking place? 6. Are you involved in training the next generation of advocates, and what do you tell them about newborn screening research? 7. How did you know leading advocacy work was your calling? Can you share your career journey? 8. The road to advocacy work is non-stop, and at times, bumpy, do you have any stories of inspiration that keep you going?  9. How can NBSTRN assist in you advocacy work? 10. What does NBS research mean to you?

https://302.buzz/PM-WhatAreYourThoughtsPatient Confidentiality is a complex subject and more times than not, the answer to the questions will begin with “Well, it depends….” Dr. Elizabeth Alderman, a pediatrician, shares her journey into pediatrics and how she has handled this issue in her own practice in the state of New York. Both Dr Gaggino and Dr. Alderman talk about the frustrations that healthcare providers face when they must decide on the best course of action to take, particularly when there are concerns about the safety and wellbeing of the adolescent patient. Listen in as they discuss navigating these complexities requiring a delicate balance between respecting a patient's confidentiality, ensuring their safety, and complying with legal and ethical obligations. [00:33 -15:50] Opening Segment / Adolescents and the 21st Century Cures ActThe 21st Century Cures Act has provided adolescents more access to confidential healthcareIt has made it easier for adolescents to receive mental health services without parental consent It has expanded access to contraception and sexual health services without parental consentIt has provided more protection for adolescents with chronic illnesses to be able to access care without parental consent.It has also strengthened HIPAA protections for adolescents.[15:51- 31:08] How can healthcare providers ensure confidentiality for adolescents? Have a routine part of the visit that discusses confidentiality and set expectations between the healthcare provider and the patient.Have a conversation with the parents or guardians about leaving the room if needed during sensitive conversations.Read the After Visit Summary before giving it to the patient to ensure that no sensitive information is included that should not be seen by parents or guardians. Work with the EHR vendor to set up rules around the patient portal that honor state law privacy exceptions.Encourage patients to ensure that their own email is linked to the patient portal instead of a parent or guardian's email.[31:09 -42:16] Empowering parents in conversations with their teensRecommending parents bring up topics like sex and drugs with their teensAssessing whether parent involvement is appropriate in each situation Discussing the limits of confidentialityRole-playing conversations with parents[42:17 - 50:37] How to Ensure Adolescents Receive Confidential Medical Care Make sure to know what state laws you are working under related to birth control, STI testing, mental health and prescribing medication for mental health disorders.Look for links and resources related to state laws and reproductive rights.Look for handouts related to adolescent confidentiality from the Society for Adolescent Health, AAP or your state's AAP chapter.Always be mindful of how your words will be interpreted by a patient.[50:38 - 59:26] Closing segment TakeawaysDon't forget to sign up for Dr. Gaggino's February 24th Beta Trainingfor Professionals who want to re-think the mental health services they offerUp Your Game - Improving Kid's Mental Health CareLinks to resources mentioned on the showState by State Variability in...

About Jordan Penn:In the past decade, Jordan Penn has spent his healthcare career as a storyteller, leveraging healthcare data and analytics to follow the patient journey, assist in research, and more. His expert knowledge of medical and pharmacy claims, lab data, and EMR/EHR data has made extraordinary contributions to his clients, he has also been deeply involved with analyzing patient journeys to support HEOR studies.At Inovalon, Jordan is a Sr. Principal Sales Engineer, working cross-functionally between sales, product, engineering, marketing, and legal to bring new ideas to existing product offerings. When Jordan is not busy bringing healthcare data to life to inform and improve treatment, he enjoys quality time with his wife and daughter in New Jersey and is an avid weightlifter. Things You'll Learn:DataStream can connect to existing EMRs and is EHR agnostic.DataStream seeks to work with clients who lack or have too much data. DataStream helps customers demystify or declutter what they have to assist providers with the insights they need when treating a patient.The HITECH act incentivized providers and hospitals to adopt electronic health records, increasing from 10% of hospitals in 2008 to over 95% for hospitals and 85% of providers eight years later.The 21st Century Cures Act vouched for interoperability and access to medical patient information without any particular need by the user.DataStream can help doctors have information about their patients on their first visit and help them establish an excellent medical relationship with them. Resources:Connect with and follow Jordan Penn on LinkedIn.Follow Inovalon on LinkedIn.Visit the Inovalon Website.

Host: Anita Murcko, MD, MACP, FAMIA Guests: Marianne Sharko, MD, MS, and Trent Rosenbloom, MD, MPH, FACMI, FAMIA Description: This podcast is focused on information blocking and sensitive health data, more specifically, the newly implemented 21st Century Cures Act and the unanticipated impact these regulations have on teens, parents, and providers. Our experts will explore the policy and practice landscape of the 21 Century Cures Act with a focus on adolescent health data sharing and its sometimes direful consequences.  

A self-described “data hippie,” Christopher Boone, vice president and global head of health economics and outcomes research at AbbVie, knows a great deal about using real-world data and generating real-world evidence in clinical trials. Boone sits with host Deborah Borfitz to talk about the disruptive presence of real-world evidence within the clinical trial enterprise and how it encourages researchers to reimagine trial design from start to finish. He says, “Much of the data we care about is captured outside the walls of the provider environment… Now, with all the digital technology, you can really understand the [patient's] environment and experience in real-time.” Boone assesses how effective the industry has been in democratizing data, how the 21st Century Cures Act was “probably the single biggest catalyst” in the expansion of real-world data, the industry's transition to patient-centered research, and the systemic and cultural barriers challenging clinical studies today. He also shares tidbits from his upcoming talk at SCOPE Summit 2023 in early February. Links from this episode: Clinical Research News AbbVie 21st Century Cures Act Patient-Centered Outcomes Research Institute (PCORI) PCORnet SCOPE Summit  

Host Dr. Nick van Terheyden, aka Dr. Nick, discusses Creating the Interstate Medical Information Highway with Elizabeth Delahoussaye, Chief Privacy Officer at CIOX. Their discussion includes, who will be the Tom Hanks actor of healthcare, 21st Century Cures Act included all “actors” including technology vendors like EMRs, all are liable for implementing interoperability. They also discuss the history and the Hitech act and how slow it was, enforcement and what's necessary to open sharing, & ultimately we must build the Info Highway for healthcare data. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In order to comply with both regulations and patient demand, health systems must provide patients with electronic access to their designated record set. But considering that patient information often resides not only in the EHR but other applications and archives, providing access to all that information in one patient portal, or even through your current Release of Information process, is tricky. That's because while patients may have a unique identifier in the main EHR, it doesn't carry over to those other data sources. Enter the need for an organization-wide unique identifier that can facilitate bringing it all together. In this timely webinar, we'll speak to leaders about how they are working to satisfy growing patient demand for access to their data and comply with the 21st Century Cures Act. Source: Developing a Multifaceted Patient Matching Strategy to Fuel Interoperability on healthsystemcio.com - healthsystemCIO.com is the sole online-only publication dedicated to exclusively and comprehensively serving the information needs of healthcare CIOs.

1st Talk Compliance features guest Rachel V. Rose, JD, MBA, principal with Rachel V. Rose – Attorney at Law, P.L.L.C., Houston, TX, on the topic of “A Business Associate Agreement? Tell Me More!” Rachel joins our host Catherine Short to discuss how Business Associate Agreements (BAA) are not new; however, some individuals are new to healthcare and others never understood what a BAA is exactly. A BAA is a contract that fundamentally gives assurances that the parties are complying with the Security Rule and Privacy Rule, setting parameters in the event of a reportable security incident or a breach, and states how the sensitive data will be returned and destroyed at the end of the relationship. This presentation not only seeks to dispel myths about why certain language is prevalent in nearly all BAAs, but also provides insight into other provisions, and items for consideration, in light of the 21st Century Cures Act.

1st Talk Compliance features guest Rachel V. Rose, JD, MBA, principal with Rachel V. Rose – Attorney at Law, P.L.L.C., Houston, TX, on the topic of “A Business Associate Agreement? Tell Me More!” Rachel joins our host Catherine Short to discuss how Business Associate Agreements (BAA) are not new; however, some individuals are new to healthcare and others never understood what a BAA is exactly. A BAA is a contract that fundamentally gives assurances that the parties are complying with the Security Rule and Privacy Rule, setting parameters in the event of a reportable security incident or a breach, and states how the sensitive data will be returned and destroyed at the end of the relationship. This presentation not only seeks to dispel myths about why certain language is prevalent in nearly all BAAs, but also provides insight into other provisions, and items for consideration, in light of the 21st Century Cures Act.

This episode's guest is Dave Navarro, Senior Director of Data Science for Harmony Healthcare IT, a data management and lifecycle solutions firm. Dave joins the Dish on Health IT host Ken Kleinberg and co-host Jocelyn Keegan to talk 21st Century Cures Act and the change in the definition of “EHI”, critical components of plans to purge, archive, or transition data to new platforms, and how to marry data in various formats and versions of CCDA and FHIR. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Our episode today focuses on a disease that's a significant problem in the US. 15% of US adults or 37 million people, are estimated to have this disease and as many as 9 in 10 adults with this disease do not know they have it. This disease is prevalent in the 65+ population. As of 2018 Medicare was spending $70B annually on the treatment of this disease which represents almost 24 % of spending for this age group. If you haven't yet figured out which disease I am referring to, its Chronic Kidney Disease or CKD. The 21st Century Cures Act brought renal diseases to the forefront and allowed Medicare Beneficiaries with ESRD to enroll in a Medicare Advantage plan. Previously, these beneficiaries were required to stay on Traditional Medicare which often resulted in suboptimal outcomes.  In addition, CMS has launched several innovative payment models in an attempt to help providers focus more on prevention and curbing progression of renal disease. As a result, many health plans and renal providers are now focused on more effectively managing renal conditions and improving outcomes. With us today is Michael Uchrin, CEO of Monogram Health, a Nashville based company that helps patients with renal disease live their best lives. The team at Monogram Health is focused on making treatments as accessible and convenient as possible to the member, by offering in-home services. Michael will help educate us on the changes that are afoot and how companies like Monogram Health are improving outcomes and lowering costs. Show Notes: Book - -Relentless: From Good To Great To Unstoppable by Tim Grover.  Nashville Healthcare Council Fellows Program: https://healthcarecouncilfellows.com/

In the uncertainty of today's healthcare industry, we must continue to persevere towards our true north.  The moral imperative to improve the quality of care for patients through better care coordination, including those are underserved, can only be achieved by the realities of the digital age. This transformation will require the medical profession to create a modernized Hippocratic Oath that extends to the broader health ecosystem. The proliferation of interoperable technology and digital health tools has the potential to catalyze value-based care delivery innovation and transparency. However, it must come along with an ethical commitment to guide data sharing, integration, and technical processes. True North will ultimately prevail in connecting value-based networks to those most in need; however, it will take continued progress in amplifying the demand signal for value-based care. On the Race to Value this week, you will hear from one of the top healthcare revolutionaries in our country.  We are honored to bring you, the one and only,Aneesh Chopra - the first chief technology officer of the United States who was appointed by President Obama and the Co-Founder and President of CareJourney. In this episode, you will be party to a powerful conversation on the promise of the digital age in healthcare.  You will learn about how health policy and innovation is ushering in a new era of data flow and interoperability, consumer-driven innovation, price transparency, and clinically-relevant analytics for the future of value-based care delivery transformation. Aneesh Chopra also explains why he feels so strongly why ACO REACH will help us reach True North. Episode Bookmarks: 01:30 Introduction to Aneesh Chopra -  - the first Chief Technology Officer of the United States and Co-Founder and President of CareJourney 04:00 The need for the medical profession to galvanize around the immense opportunity to transform care delivery by embracing the realities of digital age. 06:30 Why do we need a digital Hippocratic Oath to transform medicine? 08:00 The gap between patients being seen on a given day and the 98% of the patient panel that are not. 08:30 Designing database queries and algorithms to Identify patients in need of care. 09:30 Creating a compact between analytics communities and physicians to ensure patients are getting appropriate care. 10:45 The self-imposed barriers to technical and semantic interoperability that come from our current FFS model. 12:00 How the HITECH Act manifested in technology gaps, despite widespread EHR penetration. 14:00 “The delay in the demand signal for value-based care resulted in the de-prioritization in the market for interoperability.” 15:30 The regulatory goals of the 21st Century Cures Act to scale interoperability and eliminate information blocking. 16:45 Cures Act regulatory emphasis on population health is now reaching the market. 17:00 FHIR Interoperability Standards will ultimately deliver on the promise of population health through widespread data exchange and API-led connectivity. 18:00 Ensuring value-based care organizations a “plug and play” approach to unify electronic health records. 19:00 The promise of widespread data exchange in value-based care delivery and how it parallels with the consumer banking industry. 20:30 Similarities between Dodd-Frank Act (banking sector) and the Cures Act (healthcare sector) in regard to consumer data protections. 22:30 JPMorgan cutting off access to Mint because screen-scraping was far less secure than API connectivity. 25:00 If value-based care became the dominant delivery model, the industry wouldn't need so much regulatory oversight. 26:00 The Cures Act is beginning to reverse FFS-driven market failures in order to create a much more rational economic model. 27:00 Referencing the opinion piece in STAT by Aneesh Chopra and Seema Verma about the new price transparency regulations in healthcare.

What Goes in Your Notes? Interstate therapy practice and documentation for clients considering abortion or gender affirming care Curt and Katie chat about documentation and practice questions related to abortion or gender affirming care when providing therapy to folks in states where these types of medical care are banned or will be banned soon. We look at medical documentation privacy concerns (related to HIPAA and the 21st Century Cures Act), how therapists avoid “aiding and abetting” a client to get an abortion, what to include in your notes, and special considerations related to duty to warn and child abuse reporting. This is a law and ethics continuing education podcourse. Transcripts for this episode will be available at mtsgpodcast.com! In this podcast episode we explore post-Roe documentation for therapists We've heard a lot of questions about what therapists should do now that Roe has been overturned. We decided to dig into practice and documentation guidelines to help modern therapists navigate the changing times. Medical documentation privacy concerns with interstate practice and the new abortion bans “Your records aren't as private as you think that they are.”  - Curt Widhalm, LMFT HIPAA and the 21st Century Cures Act The impact on clients who move from safe haven states to states with abortion bans The impact of the Counseling Compact (and similar mental health compacts) and how many participating states have trigger laws to ban or limit abortion Paying attention to jurisdictional differences and where the client lives Who qualifies as a HIPAA covered entity? Psychotherapy (Process) Notes versus Progress Notes Psychotherapy notes are not defined the same and/or protected in every state The impact of civil law suits on confidentiality of process notes The huge challenge of information blocking and who may pass along your treatment information Talk to an attorney or your professional organization when subpoenaed How do you avoid “aiding and abetting” a client to get an abortion during mental health treatment? Processing feelings and helping client to make their own decisions Aiding and abetting can include telling them where to go, encouraging them to get an abortion, or providing practical support (like money or a ride) How to provide resources without aiding and abetting Self-empowerment and clients making their own decisions Liability and risk in practice (check with your malpractice insurance) Whether/how you let your clients know where you stand on the overturn of Roe v Wade What do you include in your notes when talking about abortion and gender affirming care? “You need to give meaningful consideration to what goes in [the mental health] record and you also want to be clear in what you're talking about with your clients. So, that way you're not unintentionally aiding and abetting a client who's living in one of these states where an abortion ban is currently in place.” – Curt Widhalm, LMFT What is relevant to your treatment goals? Documenting progress toward treatment goals Creating a policy related to medical decision-making Phrases that you can use to briefly describe what is happening in session How much to document and the recommendation to be less specific in progress notes when discussing medical decisions The special considerations related to duty to warn and child abuse reporting when talking about abortion and gender affirming care No case law to guide us here The difference between permissive versus required reporting Vast differences across the states with all of the different pieces HIPAA says that we should not report, but we will be impacted by state laws Recommendations to pay attention to what is happening in the states where you practice and to identify advocacy opportunities to protect information, safe haven laws Our Generous Sponsor for this episode of the Modern Therapist's Survival Guide: Thrizer Thrizer is a new modern billing platform for therapists that was built on the belief that therapy should be accessible AND clinicians should earn what they are worth. Their platform automatically gets clients reimbursed by their insurance after every session. Just by billing your clients through Thrizer, you can potentially save them hundreds every month, with no extra work on your end. Every time you bill a client through Thrizer, an insurance claim is automatically generated and sent directly to the client's insurance. From there, Thrizer provides concierge support to ensure clients get their reimbursement quickly, directly into their bank account. By eliminating reimbursement by check, confusion around benefits, and obscurity with reimbursement status, they allow your clients to focus on what actually matters rather than worrying about their money. It is very quick to get set up and it works great in completement with EHR systems. Their team is super helpful and responsive, and the founder is actually a long-time therapy client who grew frustrated with his reimbursement times The best part is you don't need to give up your rate. They charge a standard 3% payment processing fee! Thrizer lets you become more accessible while remaining in complete control of your practice. A better experience for your clients during therapy means higher retention. Money won't be the reason they quit on therapy. Sign up using bit.ly/moderntherapists if you want to test Thrizer completely risk free! Sign up for Thrizer with code 'moderntherapists' for 1 month of no credit card fees or payment processing fees! That's right - you will get one month of no payment processing fees, meaning you earn 100% of your cash rate during that time. Receive Continuing Education for this Episode of the Modern Therapist's Survival Guide Hey modern therapists, we're so excited to offer the opportunity for 1 unit of continuing education for this podcast episode – Therapy Reimagined is bringing you the Modern Therapist Learning Community!  Once you've listened to this episode, to get CE credit you just need to go to moderntherapistcommunity.com/podcourse, register for your free profile, purchase this course, pass the post-test, and complete the evaluation! Once that's all completed - you'll get a CE certificate in your profile or you can download it for your records. For our current list of CE approvals, check out moderntherapistcommunity.com. You can find this full course (including handouts and resources) here: https://moderntherapistcommunity.com/podcourse/ Continuing Education Approvals: When we are airing this podcast episode, we have the following CE approval. Please check back as we add other approval bodies: Continuing Education Information CAMFT CEPA: Therapy Reimagined is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for LMFTs, LPCCs, LCSWs, and LEPs (CAMFT CEPA provider #132270). Therapy Reimagined maintains responsibility for this program and its content. Courses meet the qualifications for the listed hours of continuing education credit for LMFTs, LCSWs, LPCCs, and/or LEPs as required by the California Board of Behavioral Sciences. We are working on additional provider approvals, but solely are able to provide CAMFT CEs at this time. Please check with your licensing body to ensure that they will accept this as an equivalent learning credit. Resources for Modern Therapists mentioned in this Podcast Episode: We've pulled together resources mentioned in this episode and put together some handy-dandy links. Please note that some of the links below may be affiliate links, so if you purchase after clicking below, we may get a little bit of cash in our pockets. We thank you in advance! 21st Century Cures Act Person-Centered Tech (help to become HIPAA compliant) What the End of Roe v. Wade Does (and Doesn't) Mean for Your Relationship With Your Therapist | by Monika Sudakov | Jul, 2022 | Medium Frequently asked questions about abortion laws and psychology practice (apaservices.org) Information blocking FAQs  HIPAA, Psychotherapy Notes, and Other Mental Health Records by Holland and Hart Additional references mentioned in this continuing education podcast: Holloway, J.D. (2003). More protections for patients and psychologists under HIPAA. American Psychological Association. https://www.apa.org/monitor/feb03/hipaa#:~:text=Under%20HIPAA%2C%20psychotherapy%20notes%20are,can%20contain%20information%20that%20is Stranger, K. (2020). HIPAA, Psychotherapy Notes, and Other Mental Health Records. https://www.jdsupra.com/legalnews/hipaa-psychotherapy-notes-and-other-42359/ U.S. Department of Health and Human Services (2013). Summary of the HIPAA Privacy Rule. https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html#:~:text=The%20Privacy%20Rule%20protects%20all,health%20information%20(PHI).%22 Zubrzycki, C. (2022) Abortion's Interoperability Trap: How the Law of Medical Records Will Facilitate Interstate Persecution of Contested Medical Procedures, and What to Do about It. Yale Law Journal Forum, Forthcoming, http://dx.doi.org/10.2139/ssrn.4147900   *The full reference list can be found in the course on our learning platform.   Relevant Episodes of MTSG Podcast: What Therapists Need to Know about Abortion and Termination for Medical Reasons: An Interview with Jane Armstrong The Practicalities of Mental Health and Gender Affirming Care for Trans Youth: An Interview with Jordan Held, LCSW Working with Trans Clients: Trans Resilience and Gender Euphoria: An interview with Beck Gee-Cohen Is the Counseling Compact Good for Therapists? Now Therapists Have to Document Every F*cking Thing in Our Progress Notes? Noteworthy Documentation: An interview with Dr. Ben Caldwell (on the 21st Century Cures Act) Who we are: Curt Widhalm, LMFT Curt Widhalm is in private practice in the Los Angeles area. He is the cofounder of the Therapy Reimagined conference, an Adjunct Professor at Pepperdine University and CSUN, a former Subject Matter Expert for the California Board of Behavioral Sciences, former CFO of the California Association of Marriage and Family Therapists, and a loving husband and father. He is 1/2 great person, 1/2 provocateur, and 1/2 geek, in that order. He dabbles in the dark art of making "dad jokes" and usually has a half-empty cup of coffee somewhere nearby. Learn more at: www.curtwidhalm.com Katie Vernoy, LMFT Katie Vernoy is a Licensed Marriage and Family Therapist, coach, and consultant supporting leaders, visionaries, executives, and helping professionals to create sustainable careers. Katie, with Curt, has developed workshops and a conference, Therapy Reimagined, to support therapists navigating through the modern challenges of this profession. Katie is also a former President of the California Association of Marriage and Family Therapists. In her spare time, Katie is secretly siphoning off Curt's youthful energy, so that she can take over the world. Learn more at: www.katievernoy.com A Quick Note: Our opinions are our own. We are only speaking for ourselves – except when we speak for each other, or over each other. We're working on it. Our guests are also only speaking for themselves and have their own opinions. We aren't trying to take their voice, and no one speaks for us either. Mostly because they don't want to, but hey. Stay in Touch with Curt, Katie, and the whole Therapy Reimagined #TherapyMovement: Patreon Buy Me A Coffee Podcast Homepage Therapy Reimagined Homepage Facebook Twitter Instagram YouTube   Consultation services with Curt Widhalm or Katie Vernoy: The Fifty-Minute Hour Connect with the Modern Therapist Community: Our Facebook Group – The Modern Therapists Group Modern Therapist's Survival Guide Creative Credits: Voice Over by DW McCann https://www.facebook.com/McCannDW/ Music by Crystal Grooms Mangano https://groomsymusic.com/

The U.S. Department of Health and Human Services (HHS) of the Office of Civil Rights (OCR) is warning healthcare providers about the mandatory compliance with the HIPAA Right of Access promulgated in the 21st Century CURES Act. So far, enforcement actions bring to 38 the number of financial penalties against HIPAA-covered entities for failing to provide patients with timely access to their medical records.During the next live edition of the long-running Talk Ten Tuesdays, nationally recognized professional coder,  auditor and consultant Terry Fletcher, reports on the do's and don'ts of withholding patient requests for their protected health information. Fletcher will also delve into the penalties and legal exposure that awaits those who are non-compliant.Other segments during the live broadcast include the following:Coding Report: Laurie Johnson, senior healthcare consultant with Revenue Cycle Solutions, LLC will report on the latest coding news.News Desk: Timothy Powell, CPA will anchor the Talk Ten Tuesdays News Desk.RegWatch: Stanley Nachimson, former CMS career professional-turned-well-known healthcare IT authority, will report on the latest regulatory news coming out of Washington, D.C.Journaling John: John Zelem, MD, FACS, founder and CEO for Streamline Solutions Consulting, will continue with his journal entry.TalkBack: Erica Remer,MD, founder and president of Erica Remer, MD, Inc. and Talk Ten Tuesdays co-host, will report on a subject that has caught her attention during her popular segment.  

On April 21, 2021 the “21st Century Cures Act” mandated that all healthcare providers grant clients/patients access to their chart “without delay” and without charge. Make sure you listen to all 3 episodes as we have noted psychiatrist and trainer in medical record keeping, Dr. Tony Thrasher, to answer our questions. In this episode, Dr. Thrasher outlines exceptional situations when the provider can keep notes private. We also discuss the importance of reviewing the prognosis with patients. Hosts: Eyrn, Toshia, Alan Guest: Tony Thrasher, MD, DFAPA

How can medical document errors become easy to fix, everywhere the error lives, & fit in the workflow? Virginia Lorenzi and HL7's Patient Empowerment Workgroup. Blog subscribers: Listen to the podcast here. Scroll down through show notes to read the post. Subscribe to Health Hats, the Podcast, on your favorite podcast player Please support my blog and podcast. CONTRIBUTE HERE Episode Notes Prefer to read, experience impaired hearing or deafness? Find FULL TRANSCRIPT at the end of the other show notes or download the printable transcript here Contents with Time-Stamped Headings to listen where you want to listen or read where you want to read (heading. time on podcast xx:xx. page # on the transcript) Proem.. 1 Introducing Virginia Lorenzi 03:31. 2 HL7's Patient Empowerment Workgroup 04:56. 2 An intelligent customer understands some of the technical 05:45. 2 Requests for corrections – a sign of engagement 07:12. 3 Fixing errors - from the fifties 08:01. 3 Patient satisfaction and errors 09:30. 4 Release more information, find more errors, feel worse 10:07. 4 Burden on clinicians, burden on patients 11:42. 4 What if you could push a button and start and track the correction process 12:12. 4 Connectathons – a meeting of the minds in a sandbox 13:17. 5 Making decisions about data standards 15:32. 5 Eureka, we have standards. Now, who's going to use them? How easy can we make it? 18:41. 6 An error is not an error, is not an error 21:11. 7 Ink on paper 24:07. 7 HIPAA-federal rules about requirements to correct errors 26:38. 8 Misdiagnosis – Out damn spot! 28:54. 9 Impact of errors 32:07. 10 Motivation to fix errors 33:50. 10 Reflection 38:44  12 Please comment and ask questions at the comment section at the bottom of the show notes on LinkedIn  via email DM on Instagram or Twitter to @healthhats Credits Music by permission from Joey van Leeuwen, Drummer, Composer, Arranger Cohelo as originally played by Mandrill, here played by Lechuga Fresca Latin Band, Danny van Leeuwen soloing on Baritone Sax Web and Social Media Coach Kayla Nelson @lifeoflesion The views and opinions presented in this podcast and publication are solely the responsibility of the author, Danny van Leeuwen, and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute®  (PCORI®), its Board of Governors or Methodology Committee. Sponsored by Abridge Inspired by and grateful to Liz Salmi, Tom Delbanco, Peter Elias, Grace Cordovana, Dave DeBronkart, Debi Willis, Laura Marcial, Bryn Rhodes Links How accurate is the medical record? A comparison of the physician's note with a concealed audio recording in unannounced standardized patient encounters in the Journal of Informatics in Health and Biomedicine the Patient Empowerment Workgroup HIPAA, you have a right to get your record fixed HIPAA rule says that if a record is amended or if a record amendment the 21st Century Cures Act. the Patient Requests for Corrections FHIR Implementation Guide United States Core Data Set for Interoperability. How to Correct Errors in Your Medical Records Correcting Errors In the Electronic Medical Record Impact of Electronic Health Record Systems on Information Integrity: Quality and Safety Implications IHE Connectathon: A Unique Testing Opportunity Late addition: Beat cancer? Your Medicare Advantage plan might still be billing for it. Related podcasts https://health-hats.com/pod158/ https://health-hats.com/opennotes-a-gold-mine-of-community-organizing/ https://health-hats.com/misdiagnosis-how-can-patients-help-doctors/ About the Show Welcome to Health Hats, learning on the journey toward best health. I am Danny van Leeuwen, a two-legged, old, cisgender, white man with privilege, living in a food oasis, who can afford many hats and knows a little about a lot of healthcare and a lot about very...

On April 21, 2021 the “21st Century Cures Act” mandated that all healthcare providers grant clients/patients access to their chart “without delay” and without charge. Make sure you listen to all 3 episodes as we have noted psychiatrist and trainer in medical record keeping, Dr. Tony Thrasher, to answer our questions. In this episode, we discuss our takes on using "woke language" in our documentation. Hosts: Eyrn, Toshia, Alan Guest: Tony Thrasher, MD, DFAPA

On April 21, 2021 the “21st Century Cures Act” mandated that all healthcare providers grant clients/patients access to their chart “without delay” and without charge. While providing access to one's chart usually works very smoothly for medical treatment, it's a different story for psychiatric and psychological treatment. For example, it's common for a client to lack insight about themselves—that's a big reason for going to therapy. So how will the treatment be affected when the client reads about how their psychologist or psychiatrist thinks they don't know what the problem actually is? Make sure you listen to all 3 episodes as we have noted psychiatrist and trainer in medical record keeping, Dr. Tony Thrasher, to help us answer these questions. Hosts: Eyrn, Toshia, Alan Guest: Tony Thrasher, MD, DFAPA

The 21st Century Cures Act made it mandatory to release scans and lab results to patients as soon as they are ready. Often, this means that they get released to patients before their doctors have seen them. While JL and Mark believe that patients should own their data, there are many sensitive situations when patients receiving their information without full understanding or explanation can have devastating results.Tweet us your questions @jeanlucneptune or @marklewismd or email us at isitserious@offscrip.com or call us at 855-283-4666.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.